Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 1402

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1402
---
. The July Note is convertible by the holder thereof in whole or in part at any time after issuance
and prior to the July Note Maturity Date into shares of Common Stock based on a conversion price (the “July Note Conversion
Price”) of $1.506 per share (the “July Note Conversion Shares”), which cannot be reduced below $0.231 per share,
and is subject to customary adjustments for stock splits, stock dividends, recapitalization and other similar transactions. Notwithstanding
the foregoing, such conversions are subject to (i) a 4.99% beneficial ownership limitation contained in the Note, which may
be increased to 9.99% upon 61 days’ prior written notice to the Company by the July Note Holder, and (ii) the Exchange Cap
(as defined below). The Company has agreed to hold a meeting of its stockholders to seek approval of a waiver of the Exchange
Cap - no later than ninety (90) days from July 24, 2024. Under the applicable rules of the NYSE American LLC, in no event may
the Company issue to July Note Holder and any of its affiliates under the CEF Purchase Agreement (as defined below), or otherwise,
more than 1,152,764 shares of Common Stock, which number of shares represents 19.99% of the shares of the Common Stock outstanding
immediately prior to the execution of the CEF Purchase Agreement (the “Exchange Cap”).

    F-18 

The
July Note is redeemable by the Company in whole or in part at any time after issuance and prior to the July Note Maturity Date
in cash at a price equal to 110% of the greater of (i) the July Note Note’s outstanding principal amount, plus all accrued
but unpaid interest and late charges due under the July Note (the “July Note Conversion Amount”) being redeemed as
of the date on which such redemption will occur (the “Company Optional Redemption Date”) and (ii) the product of (1)
the number of July Note Conversion Shares then issuable under the July Note multiplied by (2) the highest closing sale price of
the Common Stock on any trading day during the period commencing on the date immediately preceding the date of the Company Optional
Redemption Notice (as defined below) and ending on the trading day immediately prior to the date the Company makes the entire
payment. The Company may deliver only one notice to exercise its right to require redemption (the “Company